Kristoffer Maansson

Title: Kristoffer Maansson: Innovator in Pharmaceutical Chemistry

Introduction

Kristoffer Maansson is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic use. With a total of two patents to his name, Maansson's work is recognized for its potential impact on medical treatments.

Latest Patents

Maansson's latest patents focus on heteroaromatic modulators of the retinoid-related orphan receptor gamma. The first patent describes a compound characterized by a general formula where X can represent either nitrogen or carbon. The compounds are designed to include various substituents such as cyano, alkyl, and cycloalkyl groups. These compounds are intended for therapeutic applications and are included in pharmaceutical compositions, highlighting their potential utility in medicine.

Career Highlights

Kristoffer Maansson is currently employed at Leo-Pharma A/S, a company renowned for its commitment to dermatology and innovative treatments. His work at Leo-Pharma has allowed him to focus on the development of new therapeutic agents that can address unmet medical needs. His expertise in pharmaceutical chemistry has positioned him as a valuable asset to the company.

Collaborations

Maansson has collaborated with several esteemed colleagues, including Alan Stuart Jessiman and Patrick Stephen Johnson. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared research goals.

Conclusion

Kristoffer Maansson's contributions to pharmaceutical chemistry through his innovative patents and collaborations underscore his role as a significant inventor in the field. His work continues to pave the way for new therapeutic options in medicine.